-
Merck Commences Tender Offer for Inspire Pharmaceuticals at $5.00 per Share
Friday, April 15, 2011 - 9:02am | 124Merck (NYSE: MRK) today announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) for $5.00 per share in cash without interest and less any applicable withholding taxes. The tender offer is being made by Monarch Transaction Corp., a...
-
BYDUREON Recommended For Approval In Europe (LLY, ALKS)
Friday, April 15, 2011 - 8:59am | 142Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes, Inc. (Nasdaq: ALKS), announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending approval of exenatide 2...
-
Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib In Patients With Active Rheumatoid Arthritis
Friday, April 15, 2011 - 8:09am | 81Pfizer Inc. (NYSE: PFE) announced today top-line results from the ORAL Scan Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor. ORAL Scan is an ongoing two-year study in patients with moderate-to-severe active rheumatoid arthritis who had an...
-
POZEN Announces Preliminary Injunction in Treximet Patent Litigation
Friday, April 15, 2011 - 8:09am | 88POZEN Inc. (NASDAQ: POZN) announced today that the U.S. District Court for the Eastern District of Texas has granted a preliminary injunction ordering Par Pharmaceutical Inc. (NYSE: PRX) not to make, use, sell, offer to sell, or import into the United States a generic version of sumatriptan/...
-
Tongjitang Chinese Medicines Company Announces Closing of Merger and Intent to Delist from the NYSE
Friday, April 15, 2011 - 8:08am | 154Tongjitang Chinese Medicines Company (NYSE: TCM), announced today the completion of its acquisition by Hanmax Investment Limited, a British Virgin Islands business company, and Fosun Industrial Co., Limited, a company incorporated in Hong Kong. As a result of the acquisition, the Company became a...
-
Tongjitang Chinese Medicines Company Announces Closing of Merger and Intent to Delist from the NYSE (TCM)
Friday, April 15, 2011 - 8:03am | 80Tongjitang Chinese Medicines Company (NYSE: TCM), announced today the completion of its acquisition by Hanmax Investment Limited, a British Virgin Islands business company, and Fosun Industrial Co., Limited, a company incorporated in Hong Kong. As a result of the acquisition, the Company became a...
-
Piper Jaffray Reports Salix Pharmaceuticals Not Alarmed By NEJM Letters
Friday, April 15, 2011 - 7:56am | 160According to Piper Jaffray, Salix Pharmaceuticals (NASDAQ: SLXP) is not alarmed by the letter to the NEJM. Piper Jaffray reported that the April 14, 2011 issue of the New England Journal of Medicine (NEJM) featured two letters to the editor expressing misgivings regarding Xifaxan in non-...
-
A Peek Into The Market Before The Trading Starts
Friday, April 15, 2011 - 7:38am | 373Pre-open movers US stock futures are lower this morning. Futures on the Dow Jones Industrial Average fell 17 points to 12,211.00 and S&P 500 index futures dropped 1.50 points to 1,308.70. Futures on the Nasdaq 100 declined 1.25 points to 2,299.50. A Peek Into Global Markets European markets...
-
Merck Reaffirms 2011 Non-GAAP EPS Target of $3.64 to $3.76
Friday, April 15, 2011 - 7:29am | 118Following the Merck and Johnson & Johnson settlement announcement today, Merck (NYSE: MRK) said that it continues to expect 2011 non-GAAP earnings per share to be in the range of $3.64 to $3.76, excluding certain items. The 2011 non-GAAP EPS target range excludes the $500 million one-time...
-
Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck (JNJ, MRK)
Friday, April 15, 2011 - 7:29am | 283Johnson & Johnson (NYSE: JNJ) provided additional information today on its amended agreement with Merck (NYSE: MRK) regarding distribution rights for REMICADE® and SIMPONI® in markets outside the United States. The amended agreement announced today in a separate news release from both companies...
-
CEOWORLD Daily Business Roundup- China, GOOG, ZIP, BAC, MAT, HAS, GPC, KNL, SCHW, JPM, WFC…
Friday, April 15, 2011 - 7:25am | 2050The world's largest electronics retailer by sales Best Buy Co. (BBY) plan to grow its online and mobile businesses while scaling back its “big box” retail space as part of a broader strategy to combat declining sales and rising competition. China's economy grew at a slightly slower rate in the...
-
Eli Lilly, Amylin Pharmaceuticals, and Alkermes Announce BYDUREON Recommended for Approval in Europe
Friday, April 15, 2011 - 7:18am | 146Eli Lilly and Company (NYSE: LLY), together with Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes, Inc. (Nasdaq: ALKS), announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending approval of exenatide 2...
-
Merck and Johnson & Johnson Reach Agreement on Distribution Rights for REMICADE® and SIMPONI® (MRK, JNJ)
Friday, April 15, 2011 - 7:05am | 96Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Johnson & Johnson (NYSE: JNJ) and its subsidiary Centocor Ortho Biotech Inc., today announced that the companies have reached agreement to amend the distribution rights to REMICADE and SIMPONI, which treat chronic...
-
Defense is the Best Offense 04-14-2011
Thursday, April 14, 2011 - 6:35pm | 940Cusick's Corner You have heard the analogy, Defense is the best Offense, but did you think of that when you look at your portfolio. Oil and Metals have been moving this year but have definitely hit some resistance, especially with commodity inflation so prominent and expanding. This has put...
-
Hi-Tech Pharma Pops on M&A Rumors (HITK)
Thursday, April 14, 2011 - 3:58pm | 25Hi-Tech Pharma (NASDAQ: HITK) pops today on rumors that the company has put itself up for sale.